Katie Duckworth, PhD

Research Interests

Research

Quality-of-Life Evaluation After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy. Dodson RM, McQuellon RP, Mogal HD, Duckworth KE, Russell GB, Votanopoulos KI, Shen P, Levine EA. Ann. Surg. Oncol. 2016 12; 23(Suppl 5):772-783.
Hematopoietic stem cell transplant candidate and designated proxy distress levels prior to hematopoietic stem cell transplantation. Duckworth KE, Forti AM, Russell GB, Naik S, Hurd DD, McQuellon RP. Am J Hosp Palliat Care. 2014 Dec; 31(8):853-6.
The process of advance care planning in HCT candidates and proxies: self-efficacy, locus of control, and anxiety levels. Duckworth KE, Forti AM, Russell GB, Naik S, Hurd D, McQuellon RP. Am J Hosp Palliat Care. 2014 Nov; 31(7):710-6.
Patient rated outcomes and survivorship following cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (CS?+?HIPEC). Duckworth KE, McQuellon RP, Russell GB, Cashwell CS, Shen P, Stewart JH, Levine EA. J Surg Oncol. 2012 Sep; 106(4):376-80.
Health-related quality of life and cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy. McQuellon R, Duckworth KE. Curr Probl Cancer. ; 33(3):203-18.